Loading...
Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial
AIM: To investigate efficacy and safety of cetuximab combined with two chemotherapy regimens in patients with unresectable metastatic colorectal cancer (mCRC). METHODS: Randomized patients received cetuximab with 5-fluorouracil (5-FU), folinic acid (FA) and oxaliplatin (FOLFOX) 6 (arm A, n = 74) or...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The WJG Press and Baishideng
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2896750/ https://ncbi.nlm.nih.gov/pubmed/20593498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v16.i25.3133 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|